Real-time enrollment status for this nerve injury clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 8:29 PM UTC
| NCT Number | NCT06616025 |
| Recruiting Status | Recruiting |
| Condition | Nerve Injury |
| Phase | PHASE3 |
| Target Enrollment | 98 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Neuraptive Therapeutics Inc. |
| Last Updated on CT.gov | July 31, 2026 (4 weeks ago) |
As of August 28, 2026: Clinical trial NCT06616025 is currently recruiting participants. This phase3 study for nerve injury is actively seeking new participants at 24 locations across the United States. The study is sponsored by Neuraptive Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06616025 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06616025 was last updated 4 weeks ago (July 31, 2026). HelloStudys verifies this status automatically.